Cargando…
Updates in SJS/TEN: collaboration, innovation, and community
Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (SJS/TEN) is a predominantly drug-induced disease, with a mortality rate of 15–20%, that engages the expertise of multiple disciplines: dermatology, allergy, immunology, clinical pharmacology, burn surgery, ophthalmology, urogynecology, and psychia...
Ejemplares similares
-
HLA class I-drug-T-cell receptor interactions in SJS/TEN
por: Rive, Craig, et al.
Publicado: (2014) -
Disease severity and status in Stevens–Johnson syndrome and toxic epidermal necrolysis: Key knowledge gaps and research needs
por: Lehloenya, Rannakoe J.
Publicado: (2022) -
590 A Case of Chronic Urticaria Complicated by Raoultella Ornithinolytica Urinary Tract Infection, Bronchospasm and Angioedema
por: Lehloenya, Rannakoe, et al.
Publicado: (2012) -
HIV-associated photodermatitis in African populations
por: Isaacs, Thuraya, et al.
Publicado: (2023) -
Scoring Assessments in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
por: Dobry, Allison S., et al.
Publicado: (2022)